Terms: = Lymphoma AND MALAT1, PRO1073, 378938, Q9UHZ2 AND Prognosis
5 results:
1. ceRNA Network of lncRNA/miRNA as Circulating Prognostic Biomarkers in Non-Hodgkin lymphomas: Bioinformatic Analysis and Assessment of Their Prognostic Value in an NHL Cohort.
Fernandes M; Marques H; Teixeira AL; Medeiros R
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008626
[TBL] [Abstract] [Full Text] [Related]
2. Increased malat1 expression predicts poor prognosis in primary gastrointestinal diffuse large B-cell lymphoma.
Qian Z; Chen L; Wang X; Kan Y; Wang Y; Yu Y; Wang X; Zhao Z; Yang H; Ge P; Ding T; Zhai Q; Zhao H
Clin Exp Med; 2022 May; 22(2):183-191. PubMed ID: 34427833
[TBL] [Abstract] [Full Text] [Related]
3. Dysregulation of miR-335-3p, targeted by NEAT1 and malat1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia.
Pouyanrad S; Rahgozar S; Ghodousi ES
Gene; 2019 Apr; 692():35-43. PubMed ID: 30639603
[TBL] [Abstract] [Full Text] [Related]
4. Association of the long non-coding RNA malat1 with the polycomb repressive complex pathway in T and NK cell lymphoma.
Kim SH; Kim SH; Yang WI; Kim SJ; Yoon SO
Oncotarget; 2017 May; 8(19):31305-31317. PubMed ID: 28412742
[TBL] [Abstract] [Full Text] [Related]
5. Long non-coding RNA malat1 is an independent prognostic factor of osteosarcoma.
Gao KT; Lian D
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3561-5. PubMed ID: 27649655
[TBL] [Abstract] [Full Text] [Related]
